Theo Buunen PhD
Theo, who recently retired in 2012 from his position as CEO of Sanquin in Amsterdam. Sanquin, an organisation with 3,000 employees, collects blood in the Netherlands, and produces and distributes blood products and plasma products in the Netherlands and abroad. Sanquin is the result of the merger in 1997 of 22 independent blood banks and the CLB, a national plasma fractionator. In his 12 years as CEO, he reorganised the blood banking business of Sanquin from 22 separate centers into a single national blood bank with increased efficiency and quality of products.
Through internationalisation of the plasma fractionation he accomplished a significant growth in sales with the acquisition of Belgian and Finnish organisations, and by introducing Dutch plasma products to several international markets, including the US. Theo Buunen obtained his PhD in acoustics in 1976 at the University of Delft, and worked there as a scientist until 1979. He did a post doc in Madison Wisconsin from 1976-1977, and obtained an MBA at the University of Twente (Netherlands) in 1982. In 1983 he started as research manager at CLB in Amsterdam, and by 1997 he was CLB's CFO and responsible for the plasma fractionation.
He is currently on the board of several Dutch organisations in a non-executive capacity. He is chairman of the board of CAF/DCF, a Belgian fractionator in Brussels belonging to the Sanquin group, and is an executive board member of an international fractionators organisation.